Table 2.
Cancer characteristics | Results, n (%) | ||
Diagnosis | |||
|
Lobular carcinoma | 3 (12) | |
|
Ductal carcinoma | 17 (68) | |
|
Ductal carcinoma in situ | 3 (12) | |
|
Mucinous carcinoma | 1 (4) | |
|
Occult carcinoma | 1 (4) | |
Cancer type | |||
|
Triple negative | 2 (8) | |
|
HER2+a | 5 (20) | |
|
Luminal | 18 (72) | |
Familiarity | |||
|
I° breast | 8 (32) | |
|
II° breast | 6 (24) | |
|
No familiarity | 11 (44) | |
Mutation | |||
|
BRCA1 | 2 (8) | |
|
BRCA1 | 2 (8) | |
|
Negative | 6 (24) | |
|
No testing | 13 (52) |
aHER2: human epidermal growth factor receptor 2.